Antidepressant Recalled Nationwide Due to Potential Carcinogen Contamination

The FDA has issued a nationwide recall for almost 400,000 bottles of duloxetine, an antidepressant. The recall is due to high levels of a potentially cancer-causing impurity, N-nitroso-duloxetine. This Class II recall suggests a risk of temporary or reversible health issues for users.